The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK
Year of publication: |
2023
|
---|---|
Authors: | Viljoen, Adie ; Chubb, Barrie ; Malkin, Samuel J. P. ; Berry, Sasha ; Hunt, Barnaby ; Bain, Stephen C. |
Published in: |
The European journal of health economics. - Berlin : Springer, ISSN 1618-7601, ZDB-ID 2011428-X. - Vol. 24.2023, 6, p. 895-907
|
Subject: | Cost | Cost-effectiveness | Dulaglutide | Semaglutide | UK | Kosten-Wirksamkeits-Analyse | Cost-effectiveness analysis | Theorie | Theory | Soziale Kosten | Social costs | Gesundheitskosten | Health care costs | Kosten-Nutzen-Analyse | Cost-benefit analysis |
-
How relevant are social costs in economic evaluations? : the case of Alzheimer's disease
Peña-Longobardo, L. M., (2019)
-
The costs of COVID-19 and the cost-effectiveness of testing
González López-Valcárcel, Beatriz, (2021)
-
Pöhlmann, J., (2020)
- More ...
-
Cost-Effective Strategies in the Prevention of Diabetic Nephropathy
Rippin, Jonathan D., (2004)
- More ...